Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02558348
Title Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Advenchen Laboratories, LLC
Indications

fallopian tube cancer

peritoneum cancer

endometrial carcinoma

ovarian cancer

cervical squamous cell carcinoma

Therapies

Anlotinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
Huntsman Cancer Institute, University of Utah Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field